Notification of cessation of securities - NUZ
Released
Released
Announcement PDF
Appendix 3H - Notification of cessation of securities
Appendix 3H - Notification of cessation of securities 1 / 4
Announcement Summary
Entity name
NEURIZON THERAPEUTICS LIMITED
Announcement Type
New announcement
Date of this announcement
Tuesday October 13, 2026
Details of +securities that have ceased
ASX +security
code Security description
Number of
+securities that
have ceased
The +securities have
ceased due to
Date of
cessation
NUZAR OPTION EXPIRING
30-JUN-2032 EX $0.20
4,256,000 Lapse of conditional right to
securities because the
conditions have not been, or
have become incapable of
being, satisfied
14/07/2026
NUZAG PERFORMANCE RIGHTS 1,140,000 Lapse of conditional right to
securities because the
conditions have not been, or
have become incapable of
being, satisfied
14/07/2026
Refer to next page for full details of the announcement
Appendix 3H - Notification of cessation of securities
Appendix 3H - Notification of cessation of securities 2 / 4
Part 1 - Announcement Details
1.1 Name of +Entity
NEURIZON THERAPEUTICS LIMITED
We (the entity named above) provide the following information about our issued capital.
1.2 Registered Number Type
ABN
Registration Number
35094006023
1.3 ASX issuer code
NUZ
1.4 The announcement is
1.5 Date of this announcement
13/10/2026
New announcement
Appendix 3H - Notification of cessation of securities
Appendix 3H - Notification of cessation of securities 3 / 4
Part 2 - Details of +equity securities or +debt securities that have ceased
ASX +Security Code and Description
NUZAG : PERFORMANCE RIGHTS
Unquoted +equity securities that have ceased
Number of securities that have ceased
1,140,000
Reason for cessation
Lapse of conditional right to securities because the conditions have not been, or have become incapable of being,
satisfied
Date of cessation
14/7/2026
Is the entity paying any consideration for the cessation?
Any other information the entity wishes to notify to ASX about the cessation?
ASX +Security Code and Description
NUZAR : OPTION EXPIRING 30-JUN-2032 EX $0.20
Unquoted +equity securities that have ceased
Number of securities that have ceased
4,256,000
Reason for cessation
Lapse of conditional right to securities because the conditions have not been, or have become incapable of being,
satisfied
Date of cessation
14/7/2026
Is the entity paying any consideration for the cessation?
Any other information the entity wishes to notify to ASX about the cessation?
No
No
Appendix 3H - Notification of cessation of securities
Appendix 3H - Notification of cessation of securities 4 / 4
Part 3 - Issued capital following changes
Following the cessation of the +securities the subject of this notification, the issued capital of the entity will
comprise:
The figures in parts 3.1 and 3.2 below are automatically generated and may not reflect the entity's current issued capital if
other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.
3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)
ASX +security code and description
Total number of
+securities on issue
NUZ : ORDINARY FULLY PAID 791,652,365
3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)
ASX +security code and description
Total number of
+securities on issue
NUZAQ : OPTION EXPIRING 05-FEB-2028 EX $0.26 384,000
NUZAR : OPTION EXPIRING 30-JUN-2032 EX $0.20 9,539,210
NUZAA : CONVERTIBLE NOTES 750,000
NUZAB : OPTION EXPIRING 31-AUG-2033 EX $0.16 2,044,025
NUZAC : OPTION EXPIRING 31-AUG-2034 EX $0.0594 5,947,668
NUZAG : PERFORMANCE RIGHTS 16,245,860
Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by
ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in
ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class
of +security in Part 2 of this form.
Share your feedback
Discover